TBPMF News and Press, Tetra Bio-Pharma Inc From 10/07/20

DIN submission to be completed in Q4 2020 OTTAWA, ON / ACCESSWIRE / October 7, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to provide an update on its commercial strat...

NEW YORK, NY / ACCESSWIRE / October 6, 2020 / Alpha Bronze, LLC ("Alpha Bronze"), is pleased to announce that Tetra Bio-Pharma ( TSX:TBP ) ( OTCQB:TBPMF ), ("Tetra Bio-Pharma" or the "Company"), a leader in cannabinoid-derived drug discovery and development, will be presenting at Alpha Bronz...

Tetra Bio-Pharma ([[TBPMF]] -0.7%) entered into a definitive agreement with U.S. strategic partner to acquire the Canadian exclusive rights for Dronabinol Soft Gel capsules for two undisclosed milestones.Tetra will be submitting a new drug submission application in FQ4 to obtai...

Tetra is ready to submit its first New Drug Submission application to commercialize a THC-based prescription drug in Canada. Will facilitate the introduction of CAUMZ TM Significantly reinforce our core business Allows Tetra to establish a revenue stream OTTAWA...

Tetra Bio-Pharma ( OTCQB:TBPMF ) adds Ms. Dale Weil and Dr. Brent Norton to the Company's Board and appointed Dr. Graham Wood, Ph.D. as COO . More news on: Tetra Bio-Pharma Inc., Healthcare stocks news, Read more ...

OTTAWA, ON / ACCESSWIRE / September 17, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP.TO ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that Ms. Dale Weil and Dr. Brent Norton have been appointed to the Company'...

OTTAWA, ON / ACCESSWIRE / September 11, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce the appointment of Jean-Francois Boily, CPA, CA, as Chief Financial Officer an...

Brings over 20 years of commercial and medical expertise in the pharmaceutical industry and the cannabis space OTTAWA, ON / ACCESSWIRE / September 4, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and...

Pharmaceutical GMP grade QIXLEEF™ shipped OTTAWA, ON / ACCESSWIRE / September 2, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has initiated the...

Tetra defines CBD Metabolism in Humans Following QIXLEEF ™ Inhalation Data from metabolite study provides explanation for inhalation as a safe route of administration OTTAWA, ON / ACCESSWIRE / August 27, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:...